David Cutter

• Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.

  Rugbjerg K. et al, (2017), Int J Cancer, 140, 2232 - 2245

• Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.

  van Nimwegen FA. et al, (2017), Blood, 129, 2257 - 2265

• Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).

  Bright CJ. et al, (2017), Circulation, 135, 1194 - 1210

• Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.

  Fidler MM. et al, (2017), Circulation, 135, 951 - 963

• A cardiac contouring atlas for radiotherapy.

  Duane F. et al, (2017), Radiother Oncol, 122, 416 - 422

• Dose and Fractionation in Radiation Therapy of Curative Intent for Non-Small Cell Lung Cancer: Meta-Analysis of Randomized Trials.

  Ramroth J. et al, (2016), Int J Radiat Oncol Biol Phys, 96, 736 - 747

• Cardiac Mortality Among 200 000 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The Teenage and Young Adult Cancer Survivor Study.

  Henson KE. et al, (2016), Circulation, 134, 1519 - 1531

• Can Observational Data Replace Randomized Trials?

  McGale P. et al, (2016), J Clin Oncol, 34, 3355 - 3357

• Cumulative burden of disease: a relevant measure of the late side-effects of cancer treatment.

  Aznar MC. et al, (2016), Lancet Oncol, 17, 1189 - 1190

• Reply to D. Vordermark and T. Pelz and R. Mazzola et al.

  van Nimwegen FA. et al, (2016), J Clin Oncol, 34, 2941 - 2942

• Inferring the Effects of Cancer Treatment: Divergent Results From Early Breast Cancer Trialists' Collaborative Group Meta-Analyses of Randomized Trials and Observational Data From SEER Registries.

  Henson KE. et al, (2016), J Clin Oncol, 34, 803 - 809

• Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma.

  van Nimwegen FA. et al, (2016), J Clin Oncol, 34, 235 - 243

• Cardiovascular and pulmonary late effects

  Aleman BMP. and Cutter DJ., (2015), Hematologic Malignancies, 6, 411 - 425

• Population-based long-term cardiac mortality among 34,489 5-year survivors of childhood cancer

  Fidler M. et al, (2015), EUROPEAN JOURNAL OF CANCER CARE, 24, 44 - 44

• Simple method to estimate mean heart dose from Hodgkin lymphoma radiation therapy according to simulation X-rays.

  van Nimwegen FA. et al, (2015), Int J Radiat Oncol Biol Phys, 92, 153 - 160

• Risk of valvular heart disease after treatment for Hodgkin lymphoma.

  Cutter DJ. et al, (2015), J Natl Cancer Inst, 107

• Cardiovascular and pulmonary late effects

  Aleman BMP. and Cutter DJ., (2015), Hodgkin Lymphoma: A Comprehensive Overview, Second Edition, 411 - 425

• Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials.

  EBCTCG (Early Breast Cancer Trialists' Collaborative Group) None. et al, (2014), Lancet, 383, 2127 - 2135

• Long-term risk of ischemic heart disease following Hodgkin lymphoma treatment

  Van Nimwegen FA. et al, (2013), EUROPEAN JOURNAL OF CANCER, 49, S227 - S227

• Risk of ischemic heart disease in women after radiotherapy for breast cancer.

  Darby SC. et al, (2013), N Engl J Med, 368, 987 - 998

• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.

  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2012), Lancet, 379, 432 - 444

• Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2011), Lancet, 378, 1707 - 1716

• Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials.

  Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None. et al, (2011), Lancet, 378, 771 - 784

• Risks of heart disease after radiotherapy.

  Cutter DJ. et al, (2011), Tex Heart Inst J, 38, 257 - 258

• Radiation-related heart disease: current knowledge and future prospects.

  Darby SC. et al, (2010), Int J Radiat Oncol Biol Phys, 76, 656 - 665

Recent Publications

• Long-term hospitalisation rates among 5-year survivors of Hodgkin lymphoma in adolescence or young adulthood: A nationwide cohort study.

  Rugbjerg K. et al, (2017), Int J Cancer, 140, 2232 - 2245

• Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.

  van Nimwegen FA. et al, (2017), Blood, 129, 2257 - 2265

• Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).

  Bright CJ. et al, (2017), Circulation, 135, 1194 - 1210

• Population-Based Long-Term Cardiac-Specific Mortality Among 34 489 Five-Year Survivors of Childhood Cancer in Great Britain.

  Fidler MM. et al, (2017), Circulation, 135, 951 - 963

• A cardiac contouring atlas for radiotherapy.

  Duane F. et al, (2017), Radiother Oncol, 122, 416 - 422